Phase III trials of Covid-19 drug Movfor show positive results, confirms Hetero
No fatalities were reported during the study, it added.
Drug firm Hetero on Saturday announced positive results of Phase III trials of Movfor (Molnupiravir), an investigational oral antiviral COVID-19 medicine.
The results, presented…